Delivery Order SPE2DB20D1110-SPE2DB24FK05E
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $1.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564073658 MYRBETRIQ ER 25 MG TABLET 30S. The contract has a ceiling value of $1,581.55 and a performance period through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MYRBETRIQ ER 25 MG TABLET 90S. The contract has a potential value of $5,415.47 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and has not received any set-aside designations for this award. This delivery order contract is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MYRBETRIQ ER 50 MG tablets. The $5,448.95 contract has a completion date of March 12, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MYRBETRIQ ER 50 MG TABLET 90S. The $1,058.12 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MYRBETRIQ ER 50 MG TABLET 90S. The contract, valued at $4,878.73, has an ultimate completion date of February 3, 2022. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYRBETRIQ ER 50 MG TABLET 90S. The award, valued at $31,007.01, has a completion date of February 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and there are no set-aside designations on this award. The company holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,841.66 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product MYRBETRIQ ER 25 MG TABLET 30S. The award, valued at $12,556.25, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,416.29 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a prescription medication. This delivery order was placed under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for a wide range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563956659 MYRBETRIQ ER 50 MG TABLET 90S. The $16,636.96 contract has a performance period through March 14, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this order, which is issued under a larger $999,999,999.00 indefinite delivery...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FK05EDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564028065 - MYRBETRIQ ER 25 MG TABLET 90S. The $1,767.98 contract has a performance period through March 21, 2024 and does not have any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA with a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 6/19/24, 10:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/20/24 |